Physician profile
Pedram Heidari
NPI 1396184586
$12,548.19
in general payments reported to CMS, 2019-2025
6 companies · $1,844 in 2025
The $1,844 reported for 2025 was more than what 90% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,144 · 2023: $4,743 · 2024: $1,817 · 2025: $1,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,514 · Food and Beverage: $2,090 · Honoraria: $1,500 · Consulting Fee: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,514.40 |
| Food and Beverage | $2,090.25 |
| Honoraria | $1,500.00 |
| Consulting Fee | $1,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $10,115.91 | 2022-2025 | Illuccix |
| Siemens Medical Solutions USA, INC. | $1,986.59 | 2023-2025 | Biograph Vision 600 (8 Ring/64 Ct), Symbia Pro.Specta Q3, Unique Single Energy Medical Charged Particle Radiation Therapy System |
| Blue Earth Diagnostics | $254.95 | 2024 | |
| Ge Healthcare | $98.62 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $92.12 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedram Heidari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.